Artificial Intelligence-assisted Colonoscopy, Tandem Study
Launched by MAHIDOL UNIVERSITY · Jun 7, 2025
Trial Information
Current as of August 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Colon cancer accounts for one of the most common cancer worldwide and also cancer-related death. Colonoscopy is accepted to be an effective tool in colon cancer screening since the polypectomy of small adenoma can prevent colon cancer. Missed adenoma is one of the causes of interval cancer between routine colonoscopy screening. Nonvisualization is the cause of missed adenoma during colonoscopy. Artificial intelligence (AI)-assisted colonoscopy was superior then routine colonoscopy from parallel study and tandem study. Previous studies often used one same endoscopist in doing tandem colonosc...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 40 - 85 years old
- • Appointment for colonoscopy for colorectal cancer screening
- Exclusion Criteria:
- • Previous history of bowel obstruction or perforation
- • Presence of coagulopathy (Prothrombin time \>, = 3 second ULN; Platelet \< 50,000)
- • Previously diagnosed with inflammatory bowel disease or polyposis syndrome
- • Pregnancy or lactation
- • Severe comorbities or American Society of Anesthesiologist classification \>, = 3
- • Unable to sign informed consent
About Mahidol University
Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, , Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported